Jodid Draselný Unimed Pharma (Potassium Iodide)

Potassium iodide provides a stable source of iodide ions that saturate the thyroid gland. This saturation blocks the organ’s ability to absorb radioactive iodine isotopes, preventing them from being incorporated into thyroid tissue and thereby reducing radiation‑related damage while supporting normal hormone synthesis.

The appropriate dose of Jodid Draselný Unimed Pharma is determined by a qualified prescriber based on the specific exposure scenario, patient age, weight, and medical condition. Healthcare professionals follow established guidelines to calculate the correct amount for each individual case.

Safety data for potassium iodide in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Jodid Draselný Unimed Pharma, as excess iodine can affect fetal and infant thyroid function.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Potassium iodide is the most widely used agent for thyroid blockade because it directly supplies stable iodide ions, offering rapid and effective competition against radioactive iodine. Alternative agents, such as perchlorate, act by inhibiting iodine uptake but are less commonly used due to safety and efficacy considerations.

Store the product at room temperature, preferably below 25 °C, in its original packaging. Protect it from direct sunlight, moisture, and extreme temperatures to maintain stability. Ensure the container is tightly closed when not in use.

The medication is formulated for ocular administration. The prescribed amount is typically instilled into the eye according to the prescriber’s instructions, ensuring proper hygiene and avoiding contamination of the dropper tip.

Serious risks include severe allergic reactions (anaphylaxis), thyroid dysfunction such as hyperthyroidism or hypothyroidism, and, in rare cases, pulmonary edema. Patients should be monitored for signs of these conditions, especially if they have pre‑existing thyroid or renal disorders.

Individuals with known hypersensitivity to potassium iodide or any component of the formulation should avoid use. Patients with uncontrolled thyroid disease, severe renal impairment, or those taking interacting medications such as antithyroid drugs, lithium, or amiodarone should consult a healthcare professional before use.